Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01737099 · ClinicalTrials.gov registry record · NA
Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia
A NA study, sponsored by dsm-firmenich Switzerland.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT01737099 is a NA study that has completed, run by dsm-firmenich Switzerland. The registered enrollment target is 93 participants.
The verdict
NCT01737099, a NA study, has completed, sponsored by dsm-firmenich Switzerland.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the efficacy and safety of DHA-O to lower elevated triglyceride levels in healthy adults with hypertriglyceridemia.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Fish oil
- DIETARY_SUPPLEMENT DHA-O
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01737099
The ClinicalTrials.gov registry entry for NCT01737099 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is dsm-firmenich Switzerland, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01737099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01737099 about?
NCT01737099 is a clinical study titled "Efficacy and Safety Study of DHA-O in Adults With Hypertriglyceridemia". The purpose of this study is to investigate the efficacy and safety of DHA-O to lower elevated triglyceride levels in healthy adults with hypertriglyceridemia.
What is the current status of trial NCT01737099?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2012-11. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01737099?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Fish oil (DIETARY_SUPPLEMENT), DHA-O (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01737099?
This trial is sponsored by dsm-firmenich Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.